$ 150 billion! The pharmaceutical industry's largest merger finalized!

Pfizer to $ 150 billion takeover deal finally reached El build, he is expected to sign the approval of the boards of both companies on Sunday. It will also become the pharmaceutical industry's largest merger.
According to Friday's closing price of Pfizer, Ayr build than October 28 closing price of 27% of the premium. Pfizer and Al ratio of convertible plans to build 11.3: 1. The deal also involves a small portion of cash, accounts for less than 10% of the transaction price.
The acquisition of small and large, the American company Pfizer headquarters to pave the way for Ireland to achieve revenue upside (US tax rate of 35%, the Irish tax rate of 12.5%). However, in view of the transaction created the largest ever recorded medical industry, but also coincides with a key moment in American presidential election, it will inevitably lead to some controversy. In addition, Al Jian CEO Brent Saunders has caused controversy in the research and development of pharmaceutical companies. He specializes in asset transactions, corporate internal drug development skepticism future strategy after joining the new company may be subject to change.
Informed sources said Pfizer CEO Ian Read will serve as CEO of the new company, Al-built CEO Brent Saunders will serve a very senior position in the company's operations and integration, and also in the combined The Board of Directors take place.
The transaction would create an annual sales exceeding $ 60 billion pharmaceutical giant, the combined group will be ahead of the second largest US pharmaceutical companies Merck (Merck & Co), which generated sales of $ 40 billion.

( Bolise Co., Ltd. www.chemicalspharm.com )